Regulatory Approvals

FDA Approves Ustekinumab for Pediatric Ulcerative Colitis

By

Regulatory Approvals — FDA Approves Ustekinumab for Pediatric Ulcerative Colitis  Gastroenterology & Endoscopy News

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 5, 2026.

By

Related Post

Regulatory Approvals

Oncology Experts Highlight Landmark FDA Approval of Camizestrant in HR+/HER2- Advanced Breast Cancer

Regulatory Approvals

Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?

Regulatory Approvals

Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?

Financial News For All

Mergers & Acquisitions

Adobe Inc. (ADBE) Acquires Rilo to Accelerate Agentic AI — What It Means for Investors

Mergers & Acquisitions

Broad Metro acquires 65 acres for Stadium Trace Village Phase Three

Mergers & Acquisitions

Milwaukee-based Rite-Hite acquires Danish HVAC company

Mergers & Acquisitions

Real Salt Lake Acquires 20-Year-Old Canadian World Cup Defender Luc de Fougerolles From Fulham FC